Intrust Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.73M | Buy |
11,348
+438
| +4% | +$67.1K | 0.14% | 119 |
|
|
2025
Q4 | $1.5M | Buy |
10,910
+351
| +3% | +$46K | 0.12% | 121 |
|
|
2025
Q3 | $1.35M | Sell |
10,559
-8
| -0.1% | -$976 | 0.11% | 129 |
|
|
2025
Q2 | $1.28M | Sell |
10,567
-70
| -0.7% | -$7.89K | 0.11% | 135 |
|
|
2025
Q1 | $1.19M | Sell |
10,637
-276
| -3% | -$29.4K | 0.12% | 138 |
|
|
2024
Q4 | $1.06M | Buy |
10,913
+265
| +2% | +$28.3K | 0.11% | 144 |
|
|
2024
Q3 | $1.22M | Buy |
10,648
+161
| +2% | +$18.3K | 0.12% | 133 |
|
|
2024
Q2 | $1.12M | Sell |
10,487
-1,177
| -10% | -$118K | 0.12% | 133 |
|
|
2024
Q1 | $1.13M | Sell |
11,664
-719
| -6% | -$73.7K | 0.12% | 142 |
|
|
2023
Q4 | $1.25M | Buy |
12,383
+1,202
| +11% | +$116K | 0.15% | 127 |
|
|
2023
Q3 | $1.14M | Buy |
11,181
+341
| +3% | +$34.6K | 0.15% | 125 |
|
|
2023
Q2 | $1.09M | Buy |
10,840
+321
| +3% | +$32.1K | 0.13% | 137 |
|
|
2023
Q1 | $968K | Buy |
10,519
+1,170
| +13% | +$102K | 0.12% | 147 |
|
|
2022
Q4 | $848K | Buy |
9,349
+1,677
| +22% | +$141K | 0.12% | 149 |
|
|
2022
Q3 | $584K | Sell |
7,672
-281
| -4% | -$23.3K | 0.09% | 195 |
|
|
2022
Q2 | $672K | Buy |
7,953
+1,303
| +20% | +$114K | 0.1% | 186 |
|
|
2022
Q1 | $584K | Buy |
6,650
+1,773
| +36% | +$154K | 0.07% | 223 |
|
|
2021
Q4 | $427K | Sell |
4,877
-474
| -9% | -$39.4K | 0.05% | 262 |
|
|
2021
Q3 | $438K | Sell |
5,351
-831
| -13% | -$74.8K | 0.06% | 248 |
|
|
2021
Q2 | $564K | Buy |
6,182
+1,017
| +20% | +$90.6K | 0.08% | 212 |
|
|
2021
Q1 | $442K | Buy |
5,165
+387
| +8% | +$34.7K | 0.06% | 237 |
|
|
2020
Q4 | $451K | Buy |
+4,778
| New | +$418K | 0.07% | 222 |
|
|
2020
Q1 | – | Sell |
-2,429
| Closed | -$230K | – | 341 |
|
|
2019
Q4 | $230K | Buy |
2,429
+28
| +1% | +$2.51K | 0.05% | 311 |
|
|
2019
Q3 | $209K | Sell |
2,401
-26
| -1% | -$2.33K | 0.05% | 327 |
|
|
2019
Q2 | $222K | Sell |
2,427
-773
| -24% | -$65.4K | 0.05% | 330 |
|
|
2019
Q1 | $276K | Buy |
3,200
+25
| +0.8% | +$2.01K | 0.07% | 310 |
|
|
2018
Q4 | $244K | Sell |
3,175
-65
| -2% | -$5.06K | 0.07% | 311 |
|
|
2018
Q3 | $250K | Sell |
3,240
-346
| -10% | -$25.6K | 0.06% | 334 |
|
|
2018
Q2 | $243K | Sell |
3,586
-699
| -16% | -$48.2K | 0.07% | 317 |
|
|
2018
Q1 | $311K | Sell |
4,285
-744
| -15% | -$56.6K | 0.09% | 276 |
|
|
2017
Q4 | $378K | Sell |
5,029
-305
| -6% | -$23K | 0.11% | 253 |
|
|
2017
Q3 | $410K | Sell |
5,334
-48
| -0.9% | -$3.63K | 0.13% | 224 |
|
|
2017
Q2 | $403K | Sell |
5,382
-1,116
| -17% | -$79.1K | 0.14% | 217 |
|
|
2017
Q1 | $433K | Sell |
6,498
-1,748
| -21% | -$116K | 0.15% | 204 |
|
|
2016
Q4 | $538K | Sell |
8,246
-3,374
| -29% | -$219K | 0.2% | 151 |
|
|
2016
Q3 | $822K | Buy |
11,620
+21
| +0.2% | +$1.53K | 0.33% | 91 |
|
|
2016
Q2 | $857K | Buy |
11,599
+148
| +1% | +$10.2K | 0.35% | 87 |
|
|
2016
Q1 | $744K | Buy |
11,451
+2,176
| +23% | +$148K | 0.27% | 124 |
|
|
2015
Q4 | $715K | Sell |
9,275
-278
| -3% | -$22.1K | 0.27% | 121 |
|
|
2015
Q3 | $787K | Sell |
9,553
-104
| -1% | -$9.26K | 0.3% | 104 |
|
|
2015
Q2 | $851K | Buy |
9,657
+197
| +2% | +$18.1K | 0.3% | 106 |
|
|
2015
Q1 | $836K | Buy |
9,460
+1,331
| +16% | +$118K | 0.29% | 107 |
|
|
2014
Q4 | $675K | Sell |
8,129
-336
| -4% | -$27.9K | 0.25% | 120 |
|
|
2014
Q3 | $714K | Buy |
8,465
+106
| +1% | +$8.58K | 0.28% | 113 |
|
|
2014
Q2 | $678K | Buy |
8,359
+460
| +6% | +$36.2K | 0.25% | 115 |
|
|
2014
Q1 | $602K | Buy |
7,899
+920
| +13% | +$67K | 0.25% | 124 |
|
|
2013
Q4 | $503K | Buy |
6,979
+82
| +1% | +$5.7K | 0.22% | 145 |
|
|
2013
Q3 | $474K | Buy |
6,897
+120
| +2% | +$7.94K | 0.23% | 146 |
|
|
2013
Q2 | $429K | Buy |
+6,777
| New | +$441K | 0.19% | 177 |
|
Other funds holding NVS
Intrust Bank's NVS Position: Q1 2026 in Review
Intrust Bank increased its Novartis (NVS) stake by 4% in Q1 2026, buying an estimated $67.1K and bringing the position to 11,348 shares worth $1.73M. The position accounts for 0.14% of the portfolio, ranked #119.
Intrust Bank first reported a position in NVS in Q2 2013 and has held it in 49 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Intrust Bank held 11,348 shares of Novartis worth $1.73M as of Q1 2026.
- Intrust Bank bought 438 Novartis shares in Q1 2026, an estimated $67.1K.
- Novartis made up 0.14% of Intrust Bank's portfolio in Q1 2026, its #119 holding.
- Intrust Bank first reported a position in Novartis in Q2 2013 and has held it in 49 quarters since.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Intrust Bank's 13F filing for Q1 2026, filed 6 May 2026.